Ex Vivo Expansion of Circulating Tumor Cells as a Model for Cancer Predictive Pharmacology

UnknownOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

April 6, 2015

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
MelanomaCirculating Tumor Cell
Interventions
PROCEDURE

Biological sample

"Biological sample performed :~* before treatment~* 1 months after the beginning of treatment~* every tumoral assessment"

Trial Locations (1)

75010

RECRUITING

Saint-Louis Hospital, Paris

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

ScreenCell

INDUSTRY

collaborator

Celenys

UNKNOWN

collaborator

Imstar

UNKNOWN

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

Assistance Publique - Hôpitaux de Paris

OTHER